SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-029764
Filing Date
2023-05-16
Accepted
2023-05-16 16:08:52
Documents
1
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6806
  Complete submission text file 0001209191-23-029764.txt   8213
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RIVERVEST VENTURE PARTNERS 101 SOUTH HANLEY RD., STE 1850 ST. LOUIS MO 63105
Business Address
O'Donnell Niall (Reporting) CIK: 0001780235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39594 | Film No.: 23927539